These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 19308924)
21. Features of the Streptomyces hygroscopicus HtpG reveal how partial geldanamycin resistance can arise with mutation to the ATP binding pocket of a eukaryotic Hsp90. Millson SH; Chua CS; Roe SM; Polier S; Solovieva S; Pearl LH; Sim TS; Prodromou C; Piper PW FASEB J; 2011 Nov; 25(11):3828-37. PubMed ID: 21778327 [TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of macbecin as an Hsp90 inhibitor. Martin CJ; Gaisser S; Challis IR; Carletti I; Wilkinson B; Gregory M; Prodromou C; Roe SM; Pearl LH; Boyd SM; Zhang MQ J Med Chem; 2008 May; 51(9):2853-7. PubMed ID: 18357975 [TBL] [Abstract][Full Text] [Related]
23. Rational design and synthesis of ansa-adenosines as potential antitumor agents. Muranaka K; Ichikawa S; Matsuda A Nucleic Acids Symp Ser (Oxf); 2009; (53):5-6. PubMed ID: 19749232 [TBL] [Abstract][Full Text] [Related]
24. New, highly active nonbenzoquinone geldanamycin derivatives by using mutasynthesis. Eichner S; Floss HG; Sasse F; Kirschning A Chembiochem; 2009 Jul; 10(11):1801-5. PubMed ID: 19554593 [No Abstract] [Full Text] [Related]
25. Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity. Onodera H; Kaneko M; Takahashi Y; Uochi Y; Funahashi J; Nakashima T; Soga S; Suzuki M; Ikeda S; Yamashita Y; Rahayu ES; Kanda Y; Ichimura M Bioorg Med Chem Lett; 2008 Mar; 18(5):1588-91. PubMed ID: 18243703 [TBL] [Abstract][Full Text] [Related]
26. [Roles of geldanamycin biosynthetic genes in Streptomyces hygroscopicus 17997]. He W; Liu Y; Sun G; Wang Y Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1133-9. PubMed ID: 18837385 [TBL] [Abstract][Full Text] [Related]
27. New geldanamycin analogs from Streptomyces hygroscopicus. Wu CZ; Jang JH; Ahn JS; Hong YS J Microbiol Biotechnol; 2012 Nov; 22(11):1478-81. PubMed ID: 23124337 [TBL] [Abstract][Full Text] [Related]
28. Biotransformation of geldanamycin and 17-allylamino-17-demethoxygeldanamycin by human liver microsomes: reductive versus oxidative metabolism and implications. Lang W; Caldwell GW; Li J; Leo GC; Jones WJ; Masucci JA Drug Metab Dispos; 2007 Jan; 35(1):21-9. PubMed ID: 17012542 [TBL] [Abstract][Full Text] [Related]
29. Production of 17-O-demethyl-geldanamycin, a cytotoxic ansamycin polyketide, by Streptomyces hygroscopicus DEM20745. Baksh A; Kepplinger B; Isah HA; Probert MR; Clegg W; Wills C; Goodfellow M; Errington J; Allenby N; Hall MJ Nat Prod Res; 2017 Aug; 31(16):1895-1900. PubMed ID: 27966376 [TBL] [Abstract][Full Text] [Related]
30. Inside the Hsp90 inhibitors binding mode through induced fit docking. Lauria A; Ippolito M; Almerico AM J Mol Graph Model; 2009 Feb; 27(6):712-22. PubMed ID: 19084447 [TBL] [Abstract][Full Text] [Related]
31. Fluorine- and rhenium-containing geldanamycin derivatives as leads for the development of molecular probes for imaging Hsp90. Wuest F; Bouvet V; Mai B; LaPointe P Org Biomol Chem; 2012 Sep; 10(33):6724-31. PubMed ID: 22825378 [TBL] [Abstract][Full Text] [Related]
32. [Advances in antitumor activity of the hsp90 inhibitor geldanamycin]. Liao ZY; Zhen YS Yao Xue Xue Bao; 2001 Sep; 36(9):716-20. PubMed ID: 12580116 [No Abstract] [Full Text] [Related]
33. Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site. Hadden MK; Lubbers DJ; Blagg BS Curr Top Med Chem; 2006; 6(11):1173-82. PubMed ID: 16842154 [TBL] [Abstract][Full Text] [Related]
34. Learning from nature: advances in geldanamycin- and radicicol-based inhibitors of Hsp90. Kitson RR; Moody CJ J Org Chem; 2013 Jun; 78(11):5117-41. PubMed ID: 23496136 [TBL] [Abstract][Full Text] [Related]